Dr. Naveed Wagle, MD

Dr. Wagle practices at Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services.

Dr. Wagle's NPI, 1871754655, was assigned on June 24, 2008. Dr. Wagle graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2005. Dr. Wagle holds California license A100135.

Dr. Wagle's primary practice is Providence Saint John's Health Center, at 2121 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5511.

Dr. Wagle's primary practice is Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services. Dr. Wagle is also affiliated with Providence Little Company of Mary Medical Center Torrance. The medical group on file is Saint John's Physician Partners. Dmand AI also links Dr. Wagle to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wagle practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Wagle's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Wagle is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Wagle is licensed in California.

Dmand AI lists cerebrovascular disease, encephalopathy, epilepsy, head injury, hereditary polyneuropathy, mobility impairment, multiple sclerosis and neuropathy among the conditions Dr. Wagle treats.

CMS data shows 766 Medicare services from Dr. Wagle across 4 procedure codes in 2024, for 151 Medicare patients. Medicare paid $66,450 for them.

CMS counts 151 Medicare patients who saw Dr. Wagle in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wagle's median patient age at 65, with 53% women.

In 2024, Dr. Wagle wrote 141 Medicare Part D claims for 32 patients. 89% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $1,564 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

Dr. Wagle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wagle as offering telehealth.

Dmand AI links 21 papers to Dr. Wagle, published from 2012 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Brain Neoplasms. Dr. Wagle has published most often in Neurooncol Adv. Dr. Wagle's most frequent co-authors are Santosh Kesari, MD, PhD, Jose Arganda Carrillo, MD and Garni Barkhoudarian, MD.

Dmand AI links Dr. Wagle to 12 clinical trials, 4 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Gliosarcoma.

CMS Open Payments shows 140 general payments to Dr. Wagle from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Abbvie Inc. paid the most, $2,051.

Dr. Wagle graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2005. Dr. Wagle is a member of AAN.

Dr. Wagle is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.